$LRCX

Are Wall Street Analysts Predicting Lam Research Stock Will Climb or Sink?

Lam Research (LRCX) has a consensus 'Strong Buy' rating from 33 analysts, with 23 'Strong Buy' ratings, 4 'Moderate Buys,' and 6 'Holds.' The mean price target is $370.28, a 17.9% premium to the current price. TD Cowen's Krish Sankar reiterated a 'Buy' rating and $700 price target, citing growth prospects.

Original reporting
Published Aug 25, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 9:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Are Wall Street Analysts Predicting Lam Research Stock Will Climb or Sink? — source image
Decision brief

The 30-second read

$LRCXBullishMed
01

Why it matters

The upgrade and higher targets could attract new buying interest, especially from growth‑focused funds.

02

Market read

Analyst sentiment shift may act as a catalyst for short‑term price movement.

03

What to watch

Potential supply‑chain constraints and macro slowdown not addressed.

Relevance 7/10Novelty 7/10Timing: recent analyst update (Aug 15) reflected in article published Aug 25

Background

Lam Research (LRCX) is a leading supplier of wafer fabrication equipment. Analyst consensus has shifted more bullishly over the past two months.

Company-level read

Ticker impact

$LRCXBullishMedium confidence
Context

Analyst consensus upgrade to Strong Buy and new price targets ($700 high, $370.28 mean) for Lam Research.

Expected impact

Potential upside of 15‑20% if market follows new targets.

Evidence & confidence

Strong Buy consensus and high price target indicate bullish outlook; however, targets are forward‑looking and not guaranteed.

Market effects

May lift sentiment for semiconductor equipment sector.

U.S. tech equities could see modest gains.

Limited to investors tracking semiconductor supply chain.

Counterpoint

Price targets may be overly optimistic; execution risk could limit upside.

Key entities

  • TD Cowen

    Provided the $700 price target and reiterated a Buy rating.

Related articles

$AMATMedAI 8/10

Applied Materials (AMAT) Beat Estimates and Investors Sold Anyway. Lam Research Corporation (LRCX) Didn’t Have That Problem

Applied Materials (AMAT) reported Q3 earnings beating estimates, with revenue up 25% YoY to $9.12B, but shares fell 5%. Lam Research (LRCX) also beat estimates, with shares rising 6%. AMAT guided Q4 revenue to $10.25B, above expectations. Investors compared the two companies' performance in the AI-driven semiconductor equipment boom.

$LRCXMed

Chipmaking equipment supplier Lam Research to spend $3B+ on new labs

Lam Research said it will spend more than $3 billion over the next five years to expand its engineering and research labs, aiming to raise experiment capacity by over 50%. The Nasdaq-listed chipmaking equipment supplier serves memory makers including Micron, Samsung and SK hynix. The plan follows its Q2 results, with revenue up 15% to $6.72B.

$AMATMed

Applied Materials is Down 6% Premarket. Will It Drag Down Lam Research, KLA, and Other Semi Equipment Stocks?

Applied Materials (AMAT) fell about 5.7% premarket after record fiscal Q3 results but guidance for Q4 revenue and margins missed elevated expectations. The company reported record Q3 revenue of $9.1B and non-GAAP EPS of $3.50, and guided Q4 revenue to $10.25B plus or minus $500M and EPS to $4.02 plus or minus $0.20. Lam Research (LRCX) and KLA (KLAC) were little changed premarket.

$CRWVMed

Stocks Trading Higher on Favorable CPI Report and Positive AI News

Stocks rose after a favorable US CPI report, with markets reducing the odds of a 25 bp FOMC hike on Sept. 15-16. Core CPI matched a 5.5-year low. CoreWeave (CRWV) gained on Q3 revenue guidance of $3.45-$3.60B and full-year $12.4-$13.2B. Super Micro (SMCI) rose on better Q3 guidance, lifting chip stocks and SOXX.

$LRCXMedAI 8/10

Lam Research Corp (LRCX) Stock News & Articles

The article discusses ACM Research, a $5.1 billion cleaning-tool maker, and notes its results as a read on whether Chinese fabs are still buying despite export controls. It cites ACM Research Q4 2026 EPS of $1.82 (vs $1.68 est) and revenue of $6.72B (vs $6.67B est). It also mentions read-throughs to Lam Research and Applied Materials, and Lam Research’s guidance for a September-quarter revenue of $8.10B.